Ascendia Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Based in North Brunswick, New Jersey, Ascendia Pharmaceuticals is a specialty contract development and manufacturing (CDMO) company dedicated to delivering sophisticated formulations of existing drug products, and enabling formulations for preclinical- and clinical-stage drug candidates. Ascendia Pharmaceuticals is your ideal partner for: · Early stage IND-enabling formulations for toxicology and pharmacokinetic (PK) studies · Rapid development through Phase I CTM materials for oral and parenteral dosage forms · Fast discovery formulation support · Formulation development and CTM manufacturing for specialty pharmaceuticals Ascendia Pharmaceuticals also provides special development programs: · Formulations for poorly soluble and low bioavailability drugs · First-in-man injectable formulations · Nano-emulsion and nano-particle formulations · Peptide formulations · Sustained release by parenteral or oral routes · Development of 505(b)(2) products · Development of complex generics · High potency and DEA controlled drug substances · Ocular formulation development · Animal health formulations
Ascendia Pharmaceuticals has raised $5.0M across 2 funding rounds on record, the most recent an undisclosed round of $2.5M announced in Oct 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ascendia Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Ascendia Pharmaceuticals Funding Rounds
Ascendia Pharmaceuticals raised $2.5M in an undisclosed round announced in Jul 2022.
2.3 years later, an undisclosed round of $2.5M was announced in Oct 2024.
Ascendia Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Ascendia Pharmaceuticals Funding Compared to Other Biotechnology Startups
Ascendia Pharmaceuticals' latest round of $2.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ascendia Pharmaceuticals in Biotechnology and North Brunswick
Companies Similar to Ascendia Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Ascendia Pharmaceuticals Funding FAQs
What does Ascendia Pharmaceuticals do?
Based in North Brunswick, New Jersey, Ascendia Pharmaceuticals is a specialty contract development and manufacturing (CDMO) company dedicated to delivering sophisticated formulations of existing drug products, and enabling formulations for preclinical- and clinical-stage drug candidates. Ascendia Pharmaceuticals is your ideal partner for: · Early stage IND-enabling formulations for toxicology and pharmacokinetic (PK) studies · Rapid development through Phase I CTM materials for oral and parenteral dosage forms · Fast discovery formulation support · Formulation development and CTM manufacturing for specialty pharmaceuticals Ascendia Pharmaceuticals also provides special development programs: · Formulations for poorly soluble and low bioavailability drugs · First-in-man injectable formulations · Nano-emulsion and nano-particle formulations · Peptide formulations · Sustained release by parenteral or oral routes · Development of 505(b)(2) products · Development of complex generics · High potency and DEA controlled drug substances · Ocular formulation development · Animal health formulations
How much funding has Ascendia Pharmaceuticals raised?
Ascendia Pharmaceuticals has raised $5.0M across 2 rounds on record. The most recent is an undisclosed round of $2.5M announced in Oct 2024.
When did Ascendia Pharmaceuticals last raise funding?
Ascendia Pharmaceuticals' most recent funding round on record is an undisclosed round of $2.5M, announced in Oct 2024.
Who founded Ascendia Pharmaceuticals?
FundedIQ lists Jim Jingjun Huang (Founder) at Ascendia Pharmaceuticals.
Where is Ascendia Pharmaceuticals headquartered?
Ascendia Pharmaceuticals is based in North Brunswick, New Jersey, United States.
How many employees does Ascendia Pharmaceuticals have?
Ascendia Pharmaceuticals is in the 101-250 employee band.
How does Ascendia Pharmaceuticals' funding compare to other Biotechnology startups?
Ascendia Pharmaceuticals' latest round of $2.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Ascendia Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ascendia Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.